3株马赛分枝杆菌的分离鉴定及特征分析
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(31300004)。


Identification and characteristics analysis of three isolates of Mycobacterium Massiliense
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要:目的:报告对临床分离的3株马赛分枝杆菌的种型鉴定和特征分析。 方法:对3株临床分离株进行生化鉴定、16S rRNA和rpoB基因测序鉴定,用微量肉汤稀释法进行药敏实验。 结果:生化鉴定无法确定种型,且光滑型/粗糙型菌落差异明显;16S rRNA鉴定结果显示,其与龟-脓肿分枝杆菌群高度同源(相似度>99.7%),联合rpoB基因测序分析可鉴定为马赛分枝杆菌;药敏试验结果显示,其对万古霉素、利奈唑胺、头孢西丁等耐药,其中粗糙型菌耐药性更强。 结论:马赛分枝杆菌是近年来出现的新型致病菌,其粗糙型感染应予以重视。

    Abstract:

    Abstract: Objective:To identify the specific types of three clinical isolates of mycobacteria, and analyze their characteristics. Methods:The biochemical features, the sequences of 16S rRNA and rpoB gene, and the antibiotic susceptibility of three isolates were evaluated and analyzed. Results:The specific types could not be identified by traditional biochemical features. However, there were different biochemical features between smooth and rough colonies. The analysis of 16S rRNA sequence showed that there was high homology between the three isolates and the M.chelonei M.abscessus group (similarity>99.7%). Combined with the analysis of ropB gene sequence, the three isolates were identified to be M.massiliense. The antimicrobial susceptibility testing showed that the three isolates were resistant to vancomycin, linezolid and cefoxitin, especially those with the rough colony. Conclusion:M.massiliense is a pathogenic bacterium newly emerged in recent years, and its rough type infection should be paid more attention.

    参考文献
    相似文献
    引证文献
引用本文

李松,蔡杏珊,陈茶,屈平华,张伟铮,秦笙,鄂顺梅.3株马赛分枝杆菌的分离鉴定及特征分析[J].临床检验杂志,2013,31(12):908-910

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2013-01-22
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2014-01-28
  • 出版日期:
文章二维码
您是第位访问者  苏ICP备13058113号-3
苏公网安备32010202012004号
主管单位:江苏省医学会  出版单位:临床检验杂志
单位地址:江苏省南京市中央路42号  邮编:210008
电话:025-83620683 E-MAIL:lcjyzz@163.com
技术支持:北京勤云科技发展有限公司